Relief Therapeutics (RLFTF) Short Interest Ratio & Short Volume $3.04 -0.01 (-0.33%) As of 04/25/2025 11:56 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Relief Therapeutics Short Interest DataRelief Therapeutics (RLFTF) has a short interest of 400 shares. This marks a 300.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2,415 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+300.00%Dollar Volume Sold Short$1,264.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume1,141 sharesAverage Trading Volume2,415 sharesToday's Volume Vs. Average47% Short Selling Relief Therapeutics? Sign up to receive the latest short interest report for Relief Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLFTF Short Interest Over TimeRLFTF Days to Cover Over TimeRLFTF Percentage of Float Shorted Over Time Relief Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025400 shares $1,264.00 +300.0%N/A0.1 $3.16 2/28/2025100 shares $345.00 No ChangeN/A0 $3.45 1/31/2025100 shares $405.50 -88.9%N/A0 $4.06 1/15/2025900 shares $3,883.14 +80.0%N/A0.1 $4.31 12/31/2024500 shares $2,327.60 -28.6%N/A0.1 $4.66 12/15/2024700 shares $3,003.00 -41.7%N/A0.1 $4.29 11/30/20241,200 shares $6,717.60 +140.0%N/A0.2 $5.60 11/15/2024500 shares $3,470.00 -28.6%N/A0 $6.94 10/31/2024700 shares $4,410.00 -56.3%N/A0.2 $6.30 10/15/20241,600 shares $10,320.00 No ChangeN/A0.1 $6.45 Get the Latest News and Ratings for RLFTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relief Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/20241,000 shares $2,540.00 No ChangeN/A0.1 $2.54 7/15/2024100 shares $129.00 No ChangeN/A0.1 $1.29 6/30/2024100 shares $132.50 No ChangeN/A0.1 $1.33 5/31/20241,500 shares $2,280.00 +650.0%N/A0.7 $1.52 5/15/2024200 shares $284.00 -90.0%N/A0 $1.42 4/30/20242,000 shares $2,800.00 +17.7%N/A0.6 $1.40 4/15/20241,700 shares $2,244.00 -82.3%N/A0.4 $1.32 3/31/20249,600 shares $13,920.00 +123.3%N/A1.1 $1.45 3/15/20244,300 shares $6,708.00 +2.4%N/A0.7 $1.56 2/29/20244,200 shares $7,350.00 +121.1%N/A1.1 $1.75 2/15/20241,900 shares $3,686.00 -59.6%N/A0.2 $1.94 11/30/2023100 shares $228.00 No ChangeN/A0.1 $2.28 10/31/2023800 shares $1,880.00 -20.0%N/A0.2 $2.35 10/15/20231,000 shares $2,390.00 -69.7%N/A0.2 $2.39 9/30/20233,300 shares $7,920.00 +22.2%N/A0.4 $2.40 9/15/20232,700 shares $7,425.00 -38.6%N/A0.2 $2.75 8/31/20234,400 shares $13,772.00 +10.0%N/A0.3 $3.13 8/15/20234,000 shares $10,360.00 +3,900.0%N/A0.5 $2.59 7/31/2023100 shares $300.00 -88.9%N/A0 $3.00 7/15/2023900 shares $2,862.00 -97.8%N/A0.1 $3.18 6/30/202341,300 shares $128,649.50 +13.8%N/A2.3 $3.12 6/15/202336,300 shares $145,200.00 No ChangeN/A2.6 $4.00 4/30/202356,500 shares $406,800.00 +13.7%N/A0 $7.20 4/15/202349,700 shares $1,023.82 -47.1%N/A0 $0.02 3/31/202393,900 shares $2,131.53 -34.8%N/A0.1 $0.02 3/15/2023144,100 shares $2,882.00 +297.0%N/A0.1 $0.02 2/28/202336,300 shares $954.69 -40.8%N/A0 $0.03 2/15/202361,300 shares $1,569.28 +68.9%N/A0 $0.03 1/31/202336,300 shares $1,143.45 No ChangeN/A0 $0.03 1/15/202336,300 shares $1,187.01 -27.8%N/A0 $0.03From Social Security to Social Prosperity? (Ad)In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.Find out how Trump’s plan could rescue your retirement 12/30/202250,300 shares $1,473.79 +38.6%N/A0 $0.03 12/15/202236,300 shares $1,132.56 No ChangeN/A0 $0.03 11/15/2022290,700 shares $9,593.10 -20.9%N/A0.1 $0.03 10/31/2022367,600 shares $9,484.08 +25.1%N/A0.3 $0.03 10/15/2022293,900 shares $7,788.35 -83.8%N/A0.2 $0.03 9/30/20221,812,800 shares $49,489.44 +180.9%N/A0.8 $0.03 9/15/2022645,400 shares $22,201.76 +92.7%N/A0.3 $0.03 8/31/2022335,000 shares $11,348.13 -24.6%N/A0.2 $0.03 8/15/2022444,100 shares $16,387.29 +41.0%N/A0.2 $0.04 7/31/2022314,900 shares $10,785.33 -3.3%N/A0.1 $0.03 7/15/2022325,600 shares $11,884.40 -79.2%N/A0.1 $0.04 6/30/20221,563,800 shares $50,542.02 +396.1%N/A0.4 $0.03 6/15/2022315,200 shares $9,613.60 -96.4%N/A0.1 $0.03 5/31/20228,783,900 shares $382,978.04 +27.8%N/A0.7 $0.04 5/15/20226,873,900 shares $364,316.70 -8.9%N/A2.7 $0.05 4/30/20227,546,300 shares $382,974.73 +86.2%N/A2.1 $0.05 4/15/20224,052,200 shares $262,987.78 +43.7%N/A1 $0.06 3/31/20222,819,200 shares $197,062.08 -10.2%N/A1 $0.07 3/15/20223,138,900 shares $215,328.54 -48.5%N/A0.7 $0.07 2/28/20226,096,300 shares $432,837.30 +46.5%N/A1.8 $0.07 2/15/20224,161,300 shares $331,655.61 +36.2%N/A1.5 $0.08 1/31/20223,054,700 shares $229,102.50 +3.2%N/A1 $0.08 1/15/20222,961,300 shares $264,147.96 -6.3%N/A0.3 $0.09 12/31/20213,159,500 shares $205,051.55 -19.4%N/A0.3 $0.06 12/15/20213,917,500 shares $255,029.25 -3.0%N/A0.7 $0.07 11/30/20214,039,000 shares $273,844.20 +32.9%N/A0.5 $0.07 11/15/20213,039,800 shares $214,913.86 +37.5%N/A0.1 $0.07 10/29/20212,210,200 shares $197,591.88 +9.3%N/A0.2 $0.09 10/15/20212,021,500 shares $238,537.00 -49.7%N/A0.1 $0.12 9/30/20214,021,100 shares $597,133.35 -0.9%N/A0.5 $0.15 9/15/20214,059,300 shares $678,106.07 -15.3%N/A0.4 $0.17 8/31/20214,790,000 shares $967,580.00 +6.8%N/A0.6 $0.20 8/13/20214,483,600 shares $981,908.40 -5.9%N/A0.5 $0.22 7/30/20214,762,200 shares $1.15 million +366.6%N/A0.3 $0.24 7/15/20211,020,600 shares $198,608.76 +4.5%N/A0.2 $0.19 6/30/2021976,700 shares $216,339.05 -54.4%N/A0.2 $0.22 6/15/20212,142,300 shares $0.00 -20.0%N/A0.3 $0.00 5/28/20212,678,800 shares $605,341.83 -43.2%N/A0.3 $0.23 5/14/20214,718,600 shares $1.01 million -24.7%N/A0.4 $0.21 4/30/20216,266,700 shares $1.54 million -33.6%N/A0.4 $0.25 4/15/20219,431,600 shares $2.72 million +2.7%N/A1 $0.29 3/31/20219,184,300 shares $3.09 million +25.1%N/A0.6 $0.34 3/15/20217,343,600 shares $2.20 million -5.8%N/A0.6 $0.30 2/26/20217,792,100 shares $3.03 million +141.2%N/A0.3 $0.39 2/12/20213,230,400 shares $1.24 million +27.1%N/A0.1 $0.38 1/29/20212,541,200 shares $1.45 million +42.3%N/A0.2 $0.57 1/15/20211,792,700 shares $641,786.60 -14.0%N/A0.2 $0.36 12/31/20201,967,800 shares $610,018.00 +9.8%N/A0.2 $0.31 12/15/20201,792,700 shares $812,093.10 -14.0%N/A0.2 $0.45 11/30/20202,084,000 shares $924,254.00 -28.1%N/A0.1 $0.44From Social Security to Social Prosperity? (Ad)In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.Find out how Trump’s plan could rescue your retirement 11/15/20202,899,800 shares $1.03 million -9.2%N/A0.1 $0.36 10/30/20203,193,900 shares $1.68 million +24.5%N/A0.3 $0.53 10/15/20202,565,800 shares $1.44 million -9.5%N/A0.3 $0.56 9/30/20202,834,200 shares $1.51 million -24.3%N/A0.2 $0.53 9/15/20203,744,500 shares $1.90 million +126.3%N/A0.3 $0.51 8/31/20201,654,800 shares $0.00 +183.0%N/A0 $0.00 RLFTF Short Interest - Frequently Asked Questions What is Relief Therapeutics' current short interest? Short interest is the volume of Relief Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 400 shares of RLFTF short. Learn More on Relief Therapeutics' current short interest. Is Relief Therapeutics' short interest increasing or decreasing? Relief Therapeutics saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 400 shares, an increase of 300.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Relief Therapeutics stock? Short selling RLFTF is an investing strategy that aims to generate trading profit from Relief Therapeutics as its price is falling. RLFTF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relief Therapeutics? A short squeeze for Relief Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLFTF, which in turn drives the price of the stock up even further. How often is Relief Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLFTF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest Data AGTX Short Interest Data AGNPF Short Interest Data APLMW Short Interest Data ASPHF Short Interest Data AVCTF Short Interest Data AWKNF Short Interest Data AXIM Short Interest Data BCTXW Short Interest Data CDIOW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:RLFTF) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relief Therapeutics Holding SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Relief Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
